Biological tissue is notoriously difficult to see through. To visible light, a few millimeters of skin or muscle acts like a dense fog, scattering photons so aggressively that high-resolution internal imaging becomes impossible. Researchers have found a solution by moving the "viewing window" out of the visible spectrum and into the near-infrared (NIR).
By operating in specific spectral gaps—known as the first, second, and even third biological windows—scientists can bypass the scattering limits of visible light, enabling non-invasive, high-contrast visualization of structures deep within the living body.
The Problem: Why Tissue is Opaque
The primary obstacle to deep-tissue imaging is not just absorption, but scattering. When visible light (400–700 nm) hits biological tissue, it encounters a complex landscape of cells, membranes, and proteins. These structures cause photons to bounce off-course (Rayleigh and Mie scattering), blurring the image. Furthermore, biological molecules like collagen and elastin naturally glow when hit by visible light—a phenomenon called autofluorescence—which creates a "background haze" that drowns out the signal from specific fluorescent probes.
As Hao Hong and Weibo Cai explain in Imaging Gene Expression in Live Cells and Tissues, shifting emission toward longer wavelengths significantly reduces this signal loss. The physics is intuitive: longer wavelengths are less likely to be deflected by small cellular structures, allowing them to travel in a straighter path through the "fog."
The First Window (NIR-I): 700–900 nm
The first biological window (NIR-I) was the first leap beyond visible light. In this range, tissue scattering is reduced, and the absorption by blood (hemoglobin) and water is relatively low.
This window has become a staple for surgical navigation. For instance, Ann-Christin Baranski and colleagues developed dual-labeled tracers that use 800 nm fluorescence to guide the removal of prostate cancer PSMA-11–Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer. Similarly, Chaoting Zeng demonstrated that NIR-I probes allow surgeons to identify liver cancer "microfoci" smaller than 1mm that are invisible to the naked eye Intraoperative Identification of Liver Cancer Microfoci Using a Targeted Near-Infrared Fluorescent Probe for Imaging-Guided Surgery.
The Second Window (NIR-II): 1000–1700 nm
While NIR-I is a significant improvement, the real "golden window" for deep-tissue imaging lies in the NIR-II range (1000–1700 nm). In this spectrum, tissue scattering drops even further, and biological autofluorescence almost completely vanishes.
The advantage of NIR-II is clarity at depth. Shuangqi Yu and Wei Wei note that NIR-II allows for high-fidelity visualization of tumor margins at depths up to 5mm, a critical threshold for brain cancer surgery Application of nanomaterials in diagnosis and treatment of glioblastoma.
However, NIR-II introduces a new challenge: water absorption. As wavelengths increase, water in the body begins to absorb more light energy. This creates a fundamental trade-off that researchers like Zhuoran Ma have explored. In the "NIR-IIc" window (1700–2000 nm), the reduction in scattering is so extreme that it actually outweighs the increase in water absorption, allowing for 3D imaging of brain vasculature through intact bone Non-Invasive Confocal Fluorescence Imaging of Mice Beyond 1700 nm Using Superconducting Nanowire Single-Photon Detectors.
Engineering the "Glow"
To use these windows, we need materials that can actually emit NIR light. This has led to a diverse array of engineered probes:
- Chemigenetic Sensors: Helen Farrants and Yichun Shuai developed WHaloCaMP, which combines protein scaffolds with synthetic dyes to create NIR calcium indicators that are 40 times brighter than previous versions A modular chemigenetic calcium indicator enables in vivo functional imaging with near-infrared light.
- Quantum Defects: Joel Davidsson and Abhijith S Parackal have used computational screening to find defects in diamonds (like sodium) that emit specifically in the NIR biological windows for quantum-enhanced sensing Na in diamond: high spin defects revealed by the ADAQ high-throughput computational database.
- Carbon Dots: Qingyan Jia and colleagues have championed carbon-based nanomaterials as "all-in-one" agents that can both image and treat cancer in the NIR-II window Recent advances and prospects of carbon dots in cancer nanotheranostics.
Beyond Imaging: NIR for Therapy
The ability of NIR light to penetrate deep into tissue isn't just useful for seeing; it's also useful for doing. Photothermal therapy (PTT) uses NIR light to heat up nanoparticles embedded in a tumor.
Because NIR-II light (1064 nm) penetrates so deeply, Jinghua Li and Weijie Ma were able to treat deep-seated liver tumors while maintaining higher safety margins for the surrounding skin Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma. This "non-invasive scalpel" approach is also being applied to bacterial infections, where NIR light triggers the release of drugs from hydrogels deep within the body Preparation of injectable hydrogel with near-infrared light response and photo-controlled drug release.